The impact of prostate calcification on lower urinary tract symptoms

As to IPSS, no relationship was found between maximum flow rate and prostatic calcification.CONCLUSION: Prostatic calcification is not a determining factor in the assessment of LUTS severity

📌 3 Key Takeaways

🎯

Objective & Hypothesis:OBJECTIVE: We aimed to evaluate the effect of prostate calcification on lower urinary tract symptoms (LUTS).MATERIAL and METHODS: Patients who applied to urology clinic due to lower urinary system symptoms between 2010–2016 were retrospectively evaluated.

📊

Key Findings & Data:A total of 177 patients were enrolled to this study; 58 patients without calcification, 63 patients with mild calcification and 56 patients with moderate/marked calcification.

💡

Conclusion & Impact:As to IPSS, no relationship was found between maximum flow rate and prostatic calcification.CONCLUSION: Prostatic calcification is not a determining factor in the assessment of LUTS severity

🔬Design:Research Article

📍Scope:2010–2016 Verileri

⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: We aimed to evaluate the effect of prostate calcification on lower urinary tract symptoms (LUTS).MATERIAL and METHODS: Patients who applied to urology clinic due to lower urinary system symptoms between 2010–2016 were retrospectively evaluated. A total of 177 patients were enrolled to this study; 58 patients without calcification, 63 patients with mild calcification and 56 patients with moderate/marked calcification. We classified the patients into three groups; those with no calculi, with mild calcification (<3 calcification, < 3 mm length) and with moderate/marked calcification (≥3 calcification, ≥3 mm length). Patients filled the International Prostate Symptom Score (IPSS) and their maximum flow rates (Q max) were assessed. Categorical variables were evaluated with chi-square by variance analysis of continuous variables. Correlation evaluations were done by logistic regression analysis.RESULTS: The mean age was 56.5. Prostatic calcification was associated with age, but there was no positive correlation between prostate volume and PSA level, and no association with body mass index (BMI). Age adjusted analysis showed that; storage, voiding total IPSS were not correlated with calcification. As to IPSS, no relationship was found between maximum flow rate and prostatic calcification.CONCLUSION: Prostatic calcification is not a determining factor in the assessment of LUTS severity

Özet

AMAÇ: Prostat kalsifikasyonunun alt üriner sistem yakınmalarına (AÜSY) olan etkisini değerlendirmeyi amaçladık.GEREÇ ve YÖNTEMLER: 2010-2016 yılları arasında AÜSY nedeniyle üroloji polikliniğine başvuran hastalar retrospektif olarak değerlendirildi. Çalışmaya kalsifikasyonu olmayan 58 hasta, orta derecede kalsifikasyonu olan 63 hasta ve ileri derecede kalsifikasyonu olan 56 hasta olmak üzere toplam 177 hasta dahil edildi. Hastalar, daha önce tarif edildiği üzere hiç kalsifikasyonu olmayan, orta derecede kalsifikasyonu olan ( =3 adet veya >=3 mm uzunluk) olarak üç gruba ayrıldı. Hastalara uluslararası prostat semptom skoru (IPSS) doldurtuldu ve maksimum akış hızları değerlendirildi. Sürekli değişkenler varyans analizi ile kategorik değişkenler ki-kare ile değerlendirildi. Korelasyon değerlendirmeleri lojistik regresyon analizi ile yapıldı.BULGULAR: Hastaların ortalama yaşı 56,5 olarak belirlendi. Prostatik kalsifikasyon yaş ile ilişkili iken prostat volümü ile PSA düzeyi arasında pozitif bir korelasyon saptanmadı ve vücut kitle indeksi (VKİ) ile ilişkili bulunmadı. Yaşa göre düzeltilmiş olarak AÜSY ve Qmax değerinin prostatik kalsifikasyon derecesine göre değerlendirmesine göre; depolama, boşaltım ve total IPSS semptom skorları ile prostatik kalsifikasyon ilişkisiz bulundu. Maksimum akış hızı ile prostatik kalsifikasyon arasında ilişki bulunamadı.SONUÇ: Prostatik kalsifikasyonun AÜSY şiddetinin değerlendirilmesinde belirleyici bir faktör olmadığı tespit edildi

🔖

Cite This Article

KÜÇÜK, E. V., TAHRA, A., BİNDAYI, A., YILDIRIM, Ü., SOBAY, R., ŞEN, U. T. (2017). The impact of prostate calcification on lower urinary tract symptoms. Androloji Bülteni, Cilt: 19 - Sayı: 4, 123–126. https://ajindex.com/articles/148486

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Engelhardt PF, Seklehner S, Brustmann H, Riedl C, Lusuardi L. Tumor necrosis factor-α expression in patients with obstructive benign prostatic hyperplasia is associated with a higher incidence of asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification. Scand J Urol 2015;10:1–7. doi: 10.3109/21681805.2015.1044560 2. Kim SH, Jung KI, Koh JS, Min KO, Cho SY, Kim HW. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi? Urol Int 2013;90:144–9. doi: 10.1159/000342643 3. Park SW, Nam JK, Lee SD, Chung MK. Are prostatic calculi independent predictive factors of lower urinary tract symptoms? Asian J Androl 2010;12:221–6. Urol Int 2013;90:144–9. doi: 10.1038/aja.2009.75 4. Hwang EC, Choi HS, Im CM, Jung SI, Kim SO, Kang TW, et al. Prostate calculi in cancer and BPH in a cohort of Korean men: presence of calculi did not. Androl 2010;12:215–20. doi: 10.1038/ aja.2009.86 5. Shoskes DA, Lee CT, Murphy D, Kefer J, Wood HM. Incidence and significance of prostatic stones in men with chronic prostatitis/ chronic pelvic pain syndrome. Urology 2007;70:235–8. doi: 10.1016/j.urology.2007.04.008 6. Kim WB, Doo SW, Yang WJ, Song YS. Influence of prostatic calculi on lower urinary tract symptoms in middle-aged men. Urology 2011;78:447–9. doi: 10.1016/j.urology.2010.12.056 7. Rodriguez-Nieves JA, Macoska JA. Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nat Rev Urol 2013;10:546–50. doi: 10.1038/nrurol.2013.149 8. Harada K, Igari D, Tanahashi Y. Gray scale transrectal ultrasonography of the prostate. J Clin Ultrasound 1979;7:45–9. 9. Lee SE, Ku JH, Park HK, Jeong CK, Kim SH. Prostatic calculi do not influence the level of serum prostate specific antigen in men without clinically detectable prostate cancer or prostatitis. J Urol 2003;170:745–8. doi: 10.1097/01.ju.0000081650.23715.4c 10. Geramoutsos I, Gyftopoulos K, Perimenis P, Thanou V, Liagka D, Siamblis D, et al. Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults. Eur Urol 2004;45:333–7. doi: 10.1016/j.eururo.2003.09.020 11. Ficarra V, Sekulovic S, Zattoni F, Zazzera M, Novara G. Why and how to evaluate chronic prostatic inflammation. Eur Urol Suppl 2013;12:110–5. doi: 10.1016/j.eursup.2013.08.002 12. Untergasser G, Madersbacher S, Berger P. Benign prostatic hyperplasia: age-related tissue-remodeling. Exp Gerontol 2005;40:121–8. doi: 10.1016/j.exger.2004.12.0